Related Experiment Videos
Clues to cancer risk: biologic markers
American Family Physician
|March 1, 1975
Summary
Genetic and biologic studies identified key markers for "cancer family syndrome." These include the major histocompatibility system (HL-A), carcinoembryonic antigen, and viral transformation of skin fibroblasts, aiding cancer detection and prevention.
Area of Science:
- Genetics
- Oncology
- Immunology
Background:
- Two large kindreds with
- cancer family syndrome
- were investigated to understand genetic predispositions to cancer.
Purpose of the Study:
- To identify genetic and biologic markers associated with hereditary cancer syndromes.
- To explore the implications of these markers for cancer detection, control, and prevention strategies.
Main Methods:
- Genetic analysis of affected families.
- Biologic studies including assessment of major histocompatibility system (HL-A) markers.
- Evaluation of carcinoembryonic antigen (CEA) levels.
- Analysis of SV-40 viral transformation of skin fibroblasts.
- Investigation of ABO blood groups and hepatitis-associated antigen relationships to cancer.
Main Results:
- Identified potential genetic and biologic markers within the studied kindreds.
- Highlighted the major histocompatibility system (HL-A) as a potentially valuable marker.
- Indicated carcinoembryonic antigen and SV-40 viral transformation of skin fibroblasts as other significant markers.
- Ongoing studies explore relationships with ABO blood groups and hepatitis-associated antigen.
Conclusions:
- The study identified key markers with significant implications for hereditary cancer syndromes.
- These markers may enhance the early detection, control, and prevention of various cancers.
- Further research is warranted to fully elucidate the role of identified markers in cancer etiology and management.